Press Releases October 5, 2026 08:30 AM

DLH Wins $2 Million NIH Data Governance Pilot Task Order

DLH Holdings awarded $2 million NIH task order to pilot data governance framework for biomedical research data

By Priya Menon
Share
Twitter Reddit Facebook LinkedIn
DLHC

DLH Holdings Corp. has secured an NIH task order valued at $2 million to design, develop, and pilot a data governance framework ensuring secure access to controlled biomedical research data across NIH institutes. The project supports NIH-wide data policy harmonization, with emphasis on security, privacy, AI governance, and performance metrics, positioning DLH to pursue further health sector modernization opportunities.

DLH Wins $2 Million NIH Data Governance Pilot Task Order
DLHC
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • DLH will serve as technical advisor to NIH to harmonize data policies and integrate governance workflows across biomedical data platforms.
  • The task order involves piloting a secure data management approach within the National Heart, Lung, and Blood Institute and at least one other NIH entity.
  • DLH’s expertise in digital, biomedical, and AI governance underpins its role, with the project lasting 18 months and totaling $2 million in contract value.

ATLANTA, Oct. 05, 2026 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of digital, engineering, and scientific solutions for health and defense missions, today announced that it has been awarded a task order to design, develop, and pilot a data governance framework for secure access to controlled biomedical research data by the National Institutes of Health (“NIH”).

Under this task order, DLH will serve as a technical advisor to harmonize NIH and federal data policies and integrate governance workflows across biomedical data platforms, piloting a data management approach within the National Heart, Lung, and Blood Institute (“NHLBI”) and at least one other NIH Institute or Center which could serve as a roadmap for NIH-wide adoption.​ DLH will incorporate security, privacy, data rights, and artificial intelligence (“AI”) governance requirements where applicable, and collect performance metrics related to usability, compliance, interoperability, and stakeholder satisfaction.

“This award expands our role as a technical and strategic advisor to NIH and brings together DLH’s expertise in biomedical research, data governance, and secure digital solutions,” said Brooke Pierce, President of DLH’s Health business group. “We believe this work will strengthen our foundation for pursuing future enterprise-scale modernization opportunities as NIH evaluates broader adoption of the framework.”

This task order represents new work for DLH and has a total value of $2 million over an eighteen-month period of performance.

About DLH

DLH (NASDAQ: DLHC) enhances technology, public health, and cyber security readiness missions through science, technology, cyber, and engineering solutions and services. Our experts solve some of the most complex and critical missions faced by federal customers, leveraging digital transformation, artificial intelligence, advanced analytics, cloud-based applications, telehealth systems, and more. With a world-class workforce dedicated to the idea that “Your Mission is Our Passion,” DLH brings a unique combination of government sector experience, proven methodology, and unwavering commitment to innovative solutions to improve the lives of millions. For more information, visit www.DLHcorp.com.

Contact Information:

Investor Relations

[email protected]

Media

[email protected]

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995:

This press release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements relate to future events or DLH`s future financial performance. Any statements that refer to expectations, projections or other characterizations of future events or circumstances or that are not statements of historical fact (including without limitation statements to the effect that the Company or its management “believes”, “expects”, “anticipates”, “plans”, “intends” and similar expressions) should be considered forward-looking statements that involve risks and uncertainties which could cause actual events or DLH’s actual results to differ materially from those indicated by the forward-looking statements. Forward-looking statements in this release include, among others, statements regarding expected contract performance, future task order value, and anticipated operational benefits. These statements reflect our belief and assumptions as to future events that may not prove to be accurate. Our actual results may differ materially from such forward-looking statements due to a variety of factors, including: the failure to achieve the anticipated benefits of any future acquisition (including anticipated future financial operating performance and results); the inability to retain employees and customers; contract awards in connection with re-competes for present business and/or competition for new business; our ability to manage our debt obligations; compliance with bank financial and other covenants; changes in client budgetary priorities; government contract procurement (such as bid and award protests, small business set asides, loss of work due to organizational conflicts of interest, etc.) and termination risks; significant delays or reductions in appropriations for our programs and broader changes in U.S. government funding and spending patterns; legislation that amends or changes discretionary spending levels or budget priorities; legal, regulatory, and political changes from the federal government that could result in economic uncertainty; the impact of inflation and higher interest rates; and other risks described in our SEC filings. For a discussion of such risks and uncertainties which could cause actual results to differ from those contained in the forward-looking statements, see “Risk Factors” in the Company’s periodic reports filed with the SEC, including our Annual Report on Form 10-K for the fiscal year ended September 30, 2025, as well as interim quarterly filings thereafter. The forward-looking statements contained herein are not historical facts, but rather are based on current expectations, estimates, assumptions and projections about our industry and business. Such forward-looking statements are made as of the date hereof and may become outdated over time. The Company does not assume any responsibility for updating forward-looking statements.


Risks

  • Potential delays or funding reductions in NIH or federal government appropriations could impact contract fulfillment and DLH’s revenue streams.
  • Competitive pressures and risks inherent to government contract awards, including re-competes and bid protests, may affect future business opportunities.
  • Implementation challenges in integrating complex data governance frameworks across multiple NIH institutes could affect timelines and performance outcomes.

More from Press Releases

Hunter Fan Company Expands Jasmine Roth Lighting Collection Oct 5, 2026 Assembly Biosciences to Present Positive Phase 1a Safety, Tolerability and Target Engagement Data for ABI-6250 at AASLD The Liver Meeting® 2026 Oct 5, 2026 LKQ Corporation to Release Third Quarter 2026 Results on Thursday, October 29, 2026 Oct 5, 2026 Alpha Tau to Participate in October Investor Conferences Oct 5, 2026 Uniti Fiber and New Orleans Saints Announce Fiber-Backed Partnership to Support Connected Gameday and Business Operations Oct 5, 2026